Iridex
IRIX • NASDAQ
Iridex is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Patrick Mercer, with a market cap of $17.0M.
CEOPatrick Mercer
Next Earnings
Upcoming earnings announcement for Iridex
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.05
Revenue Estimate
$13.2M
Earnings History
Past 12 earnings reports for Iridex
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.01Est: -$0.02 | +50.0% | $14.7MEst: $14.7M | -0.1% | — |
| Nov 11, 2025 | Q3 2025 | -$0.09 | — | $12.5M | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.06Est: $0.06 | -200.0% | $13.6M | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.10 | — | $11.9M | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.05 | — | $12.7M | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.12Est: -$0.09 | -33.3% | $11.6MEst: $12.5M | -7.4% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.16Est: -$0.12 | -33.3% | $12.6MEst: $12.8M | -1.3% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.21Est: -$0.12 | -75.0% | $11.8MEst: $12.0M | -2.0% | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.18Est: -$0.05 | -260.0% | $12.5MEst: $14.9M | -16.4% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.11Est: -$0.12 | +8.3% | $12.9MEst: $13.5M | -4.7% | — |
| Aug 10, 2023 | Q2 2023 | -$0.17Est: -$0.11 | -54.5% | $12.9MEst: $14.2M | -9.7% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.13Est: -$0.12 | -8.3% | $13.7MEst: $13.6M | +0.5% | 10-Q |